Skip to main content
  • Research Article
  • Open access
  • Published:

Canola oil decreases cholesterol and improves endothelial function in patients with peripheral arterial occlusive disease — a pilot study

Summary

Background

Dietary supplementation with omega-3 PUFAs has been shown to reduce cardiovascular morbidity and mortality. This pilot study investigated the effects of supplementation with plant-derived omega-3 and omega-6 PUFAs in patients with atherosclerosis.

Methods

Forty patients with PAD supplemented their usual diet with 2 tablespoons/day of canola oil (n = 20) or sunflower oil (n = 20), containing 2.24 g of a-linolenic acid or 16.24 g of linoleic acid, respectively, for 8 weeks. Laser Doppler flux (LDF), was assessed at rest and during reactive hyperaemia. Other measurements included parameters of heart rate variability (HRV), markers of plasmatic coagulation, fibrinolysis, platelet activation, inflammation, and lipid and homocysteine levels.

Results

Despite randomization, baseline values for LDF and HRV differed between the two groups. LDL-cholesterol decreased (from 2.74 ± 0.73 to 2.42 ± 0.65 mmol/L, p = 0.007) with canola oil but not with sunflower oil. The difference in the percent increase of LDF after ischemic challenge increased with canola oil from a median (25th; 75th percentiles) of 75.2% (48.6; 161.2) to 151.7% (117.8; 260.0) (p = 0.008) and with sunflower oil from 157.9% (125.4; 229.8) to 178.6% (127.3; 356.3) (p = 0.03), whereas a control group did show no change. HRV and other markers did not change.

Conclusions

Canola oil containing omega-3 PUFAs may confer cardiovascular protection by improving endothelial function and lowering LDL-cholesterol, but additional studies are warranted.

Abbreviations

%RR50:

the percent difference between adjacent RR intervals that were greater than 50 msec

ALA:

α-linolenic acid

DHA:

docosapentaneoic acid

DD:

D-dimers

EPA:

eicosapentaneoic acid

F1 + 2:

prothrombin fragment 1 + 2

FMD:

flow-mediated dilation

GISSI:

gruppo italiano per lo studio della sopravvivenza nell’infarto miocardio

LA:

linoleic acid

LDF:

laser Doppler flow

NO:

nitric oxide

PAD:

peripheral artery occlusive disease

PAI-1:

plasminogen activator inhibitor-1

PUFA:

polyunsaturated fatty acid

rmsSD:

the square root of the mean of the sum of the squares of differences between adjacent RR intervals

SDANN:

the standard deviation of the normal RR intervals averaged over 5 min intervals during the monitoring period

SDNN:

the standard deviation of all normal RR intervals observed over the monitoring period

TAT:

thombin-antithrombin complex

t-PA:

tissue-type plasminogen activator

References

  1. Knoops KT, de Groot LC, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004;292:1433–9.

    Google Scholar 

  2. Simopoulos AP. Evolutionary aspects of diet, essential fatty acids and cardiovascular disease. Eur Heart J Suppl 2001; 3(Suppl D):D8–21.

    Google Scholar 

  3. Kris-Etherton PM, Harris WS, Appel LJ. American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106:2747–57.

    Google Scholar 

  4. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 2006;332:752–60.

    Google Scholar 

  5. Mozaffarian D, Ascherio A, Hu FB, Stampfer MJ, Willett WC, Siscovick DS, et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 2005;111:157–64.

    Google Scholar 

  6. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004;292: 1440–6.

    Google Scholar 

  7. Leaf A. On the reanalysis of the GISSI-Prevenzione. Circulation 2002;105:1874–5.

    Google Scholar 

  8. Din JN, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease-fishing for a natural treatment. BMJ 2004; 328:30–5.

    Google Scholar 

  9. Harris WS. Alpha-linolenic acid: a gift from the land? Circulation 2005;111:2872–4.

    Google Scholar 

  10. Li D, Sinclair A, Wilson A, Nakkote S, Kelly F, Abedin L, et al. Effect of dietary alpha-linolenic acid on thrombotic risk factors in vegetarian men. Am J Clin Nutr 1999;69:872–82.

    Google Scholar 

  11. Wendland E, Farmer A, Glasziou P, Neil A. Effect of alpha linolenic acid on cardiovascular risk markers: a systematic review. Heart 2006;92:166–9.

    Google Scholar 

  12. Heller A, Koch T, Schmeck J, van Ackern K. Lipid mediators in inflammatory disorders. Drugs 1998;55:487–96.

    Google Scholar 

  13. Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J 2004;25:1197–207.

    Google Scholar 

  14. Durand P, Prost M, Loreau N, Lussier-Cacan S, Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 2001;81:645–72.

    Google Scholar 

  15. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135–43.

    Google Scholar 

  16. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002;112:298–304.

    Google Scholar 

  17. Zhao G, Etherton TD, Martin KR, West SG, Gillies PJ, Kris-Etherton PM. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 2004;134:2991–7.

    Google Scholar 

  18. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454–9.

    Google Scholar 

  19. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447–55.

    Google Scholar 

  20. Lee KW, Lip GY. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 2003;163:2368–92.

    Google Scholar 

  21. Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol 2004;44:152–8.

    Google Scholar 

  22. Piolot A, Blache D, Boulet L, Fortin LJ, Dubreuil D, Marcoux C, et al. Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health. J Lab Clin Med 2003;141:41–9.

    Google Scholar 

  23. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005;111:363–8.

    Google Scholar 

  24. Khan F, Elherik K, Bolton-Smith C, Barr R, Hill A, Murrie I, et al. The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects. Cardiovasc Res 2003;59:955–62.

    Google Scholar 

  25. GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002;105:1897–903.

    Google Scholar 

  26. Binggeli C, Spieker LE, Corti R, Sudano I, Stojanovic V, Hayoz D, et al. Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients:amonitoring test ofendothelial dysfunction for clinical practice? J Am Coll Cardiol 2003;42:71–7.

    Google Scholar 

  27. Binkley PF, Haas GJ, Starling RC, NunziataE,Hatton PA, Leier CV, et al. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol 1993;21:655–61.

    Google Scholar 

  28. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23:168–75.

    Google Scholar 

  29. Sola S, Mir MQ, Cheema FA, Khan-Merchant N, Menon RG, Parthasarathy S, et al. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation 2005;111:343–8.

    Google Scholar 

  30. Ros E, Nunez I, Perez-Heras A, Serra M, Gilabert R, Casals E, et al. A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 2004;109:1609–14.

    Google Scholar 

  31. Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, et al. Fatty Acid Antiarrhythmia Trial Investigators. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005;112:2762–8.

    Google Scholar 

  32. de Lorgeril M, Salen P. Alpha-linolenic acid and coronary heart disease. Nutr Metab Cardiovasc Dis 2004;14:162–9.

    Google Scholar 

  33. Sanderson P, Finnegan YE, Williams CM, Calder PC, Burdge GC, Wootton SA, et al. UK food standards agency a-linolenic acid workshop report. Br J Nutr 2002;88:573–9.

    Google Scholar 

  34. Chisholm A, McAuley K, Mann J, Williams S, Skeaff M. Cholesterol lowering effects of nuts compared with a canola oil enriched cereal of similar fat composition. NMCD 2005;15:284–92.

    Google Scholar 

  35. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972–8.

    Google Scholar 

  36. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothe-lial dysfunction in coronary microcirculation of hypercholester-olaemic patients by L-arginine. Lancet 1991;338:1546–50.

    Google Scholar 

  37. Celermajer DS. Statins, skin, and the search for a test of endothelial function. J Am Coll Cardiol 2003;42:78–80.

    Google Scholar 

  38. Stroes ES, Koomans HA, de Bruin TW, Rabelink TJ. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 1995;346:467–71.

    Google Scholar 

  39. Cortes B, Nunez I, Cofan M, Gilabert R, Pérez-Heras A, Casals E, et al. Acute effects of high-fat meals enriched with walnuts or olive oil on postprandial endothelial function. J Am Coll Cardiol 2006;48:1666–71.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hans Stricker.

Additional information

Funding Sources: The study was partly funded by the Fondo Balli, Locarno, Switzerland.

Rights and permissions

This is an open access article distributed under the CC BY-NC license. https://doi.org/creativecommons.org/licenses/by/4.0/

Reprints and permissions

About this article

Cite this article

Stricker, H., Duchini, F., Facchini, M. et al. Canola oil decreases cholesterol and improves endothelial function in patients with peripheral arterial occlusive disease — a pilot study. Artery Res 2, 67–73 (2008). https://doi.org/10.1016/j.artres.2008.02.001

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.artres.2008.02.001

Keywords